DekaBank Deutsche Girozentrale’s Juno Therapeutics, Inc. JUNO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-61,900	Closed	-$1.71M	–	1238
2017 Q4	$1.71M	Hold	61,900	–	–	0.01%	583
2017 Q3	$1.71M	Buy	61,900 +13,500	+28%	+$460K	0.01%	590
2017 Q2	$1.46M	Hold	48,400	–	–	0.01%	609
2017 Q1	$1.06M	Buy	+48,400	New	+$1.04M	0.01%	607
2016 Q3	–	Sell	-60,000	Closed	-$2.37M	–	1059
2016 Q2	$2.37M	Buy	60,000 +12,800	+27%	+$531K	0.03%	434
2016 Q1	$1.74M	Buy	+47,200	New	+$1.64M	0.02%	464
2015 Q1	–	Sell	-48,700	Closed	-$2.64M	–	1182
2014 Q4	$2.64M	Buy	+48,700	New	+$2.18M	0.03%	415

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

DekaBank Deutsche Girozentrale's JUNO Position: Q1 2018 in Review

DekaBank Deutsche Girozentrale sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 61,900 shares — an estimated $1.71M sold.

DekaBank Deutsche Girozentrale first reported a position in JUNO in Q4 2014 and held it in 7 quarters. The position peaked at $2.64M in Q4 2014. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

DekaBank Deutsche Girozentrale reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 61,900 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.71M.
DekaBank Deutsche Girozentrale first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's Juno Therapeutics, Inc. position peaked at $2.64M in Q4 2014.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2018, filed 3 May 2018.